About Medix Biochemica
Medix Biochemica is a Healthcare company based in Espoo (Finland) founded in 1985, and was acquired by DevCo in December 2018. It develops and markets rapid diagnostic tests and bioreagents. Medix Biochemica has completed 6 acquisitions, including Bioresource Technology, Biostride and EastCoast Bio. Its website medixbiochemica.com draws about 23 thousand monthly visits. Medix Biochemica offers products and services including Antibodies, Antigens, Biospecimens, Enzymes, and Immunoassay Kits. Its focus areas include Diversified Diagnostics.
Company details
Medix Biochemica is engaged in the development, manufacturing, and marketing of POC tests for human disease diagnosis and bioreagents including monoclonal antibodies, antibody services and recombinant antigens for diagnostic market. The company offers monoclonal antibodies and antigens for cardiovascular, diabetes, fertility, infectious diseases, metabolism, serology, thyroid and tumor fields. The rapid tests are available for detection of premature rupture of fetal membranes, acute pancreatitis, Influenza A B, fecal occult blood, CRP, and Respiratory syncytial virus. Ina addition, the company offers customized services such as recombinant antibody development, contract manufacturing of antibodies, antibody conjugation and coating of microplates.
- Headquarters Espoo, Finland
- Stage Acquired
- SectorsHealthcare
- Website medixbiochemica.com
- Social LinkedIn Facebook YouTube
- Acquired by DevCo (Dec 2018)
- Investors
- Investments & AcquisitionsBioresource Technology
& 5 more
- Acquired byDevCo
(Dec 2018)
Products & Services of Medix Biochemica
Medix Biochemica offers a comprehensive portfolio of products and services, including Antibodies, Antigens, Biospecimens, Enzymes, and Immunoassay Kits.
Monoclonal and polyclonal antibodies for immunoassay tests
Native and recombinant antigens for assay development
Ethically sourced fluids and tissues for research applications
Clinical chemistry enzymes for quality control and assays
Kits for detecting various clinical markers and diseases
Apps and channels of Medix Biochemica
its YouTube channel Medix Biochemica has 67 subscribers and 19 videos.
Videos from Medix Biochemica
The most watched videos on Medix Biochemica's YouTube channel, Medix Biochemica (67 subscribers). Click a video to play it here.
More on Medix Biochemica.
Investors in Medix Biochemica
Medix Biochemica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DevCo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Active ownership and development support are provided to niche companies. | 2014 | devco.fi | Helsinki, Finland |
Investor details for Medix Biochemica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medix Biochemica
Medix Biochemica has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Bioresource Technology, Biostride and EastCoast Bio.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Infectious disease antibody reagents are supplied for diagnostics and research. | virostat-inc.com | Portland, United States | 1985 | Nov 2023 | •••• | |
Human serum, plasma, diagnostic matrices, and OEM controls are manufactured. | brt-us.com | Weston, United States | 1984 | Jun 2022 | •••• | |
Engineered DNA polymerases are supplied for molecular biology uses. | mypols.de | Konstanz, Germany | 2014 | Feb 2022 | •••• | |
Provider of web hosting and domain registration services | eastcoastbio.com | North Berwick, United States | 1995 | Jun 2020 | •••• | |
Antibodies, antigens, and enzyme conjugates are developed and manufactured. | biostrideinc.com | Redwood, United States | 1990 | Jun 2020 | •••• | |
Lifescience reagents are manufactured for clinical diagnostic tests. | leebio.com | Maryland Heights, United States | 1975 | Oct 2019 | •••• |
Complete acquisition details for Medix Biochemica
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medix Biochemica
8 dated milestones of Medix Biochemica across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Medix Biochemica is founded.
- Exit Acquired by DevCo.
- Acquisition Acquires Lee Biosolutions.
- Acquisition Acquires EastCoast Bio.
- Acquisition Acquires Biostride.
- Acquisition Acquires myPOLS Biotec.
- Acquisition Acquires Bioresource Technology.
- Acquisition Acquires ViroStat.
Web traffic of Medix Biochemica
The website of Medix Biochemica (medixbiochemica.com) receives about 22.5K visits a month.
- Monthly visits22.5K
▲ 24.7% vs previous month
Websites whose visitors overlap most with Medix Biochemica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oriondiagnostica.com | 100% | View details | |||
| yml.fi | 96% | 13.3K | #1,728,409 | View details | |
| dako.com | 87% | 1.6K | #11,422,431 | View details | |
schooltiters.com | schooltiters.com | 75% | #2,430,598 | – | |
| medicalbuyer.co.in | 69% | #581,341 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Medix Biochemica
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medix Biochemica
Complete news archive for Medix Biochemica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medix Biochemica
Medix Biochemica was founded in 1985.
Medix Biochemica is headquartered in Espoo, Finland.
Medix Biochemica is engaged in the development, manufacturing, and marketing of POC tests for human disease diagnosis and bioreagents including monoclonal antibodies, antibody services and recombinant antigens for diagnostic market. The company offers monoclonal antibodies and antigens for cardiovascular, diabetes, fertility, infectious diseases, metabolism, serology, thyroid and tumor fields. The rapid tests are available for detection of premature rupture of fetal membranes, acute pancreatitis, Influenza A B, fecal occult blood, CRP, and Respiratory syncytial virus. Ina addition, the company offers customized services such as recombinant antibody development, contract manufacturing of antibodies, antibody conjugation and coating of microplates.
Medix Biochemica offers Antibodies, Antigens, Biospecimens, Enzymes, and Immunoassay Kits.
Medix Biochemica has made 6 acquisitions, including Bioresource Technology, Biostride, and EastCoast Bio.
Medix Biochemica has 1 investor. Key investors include DevCo.
Yes. Medix Biochemica was acquired by DevCo in December 2018.